CHITI, ARTURO
 Distribuzione geografica
Continente #
NA - Nord America 494
EU - Europa 471
AS - Asia 294
OC - Oceania 31
AF - Africa 7
SA - Sud America 3
Totale 1.300
Nazione #
US - Stati Uniti d'America 489
IT - Italia 223
RU - Federazione Russa 144
SG - Singapore 133
CN - Cina 122
SE - Svezia 45
AU - Australia 31
DE - Germania 19
FI - Finlandia 14
TH - Thailandia 10
HK - Hong Kong 8
GB - Regno Unito 7
JP - Giappone 5
AT - Austria 4
IN - India 4
TR - Turchia 4
CO - Colombia 3
EG - Egitto 3
MX - Messico 3
BG - Bulgaria 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
NL - Olanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CU - Cuba 1
DK - Danimarca 1
HU - Ungheria 1
IE - Irlanda 1
PH - Filippine 1
RO - Romania 1
UA - Ucraina 1
Totale 1.300
Città #
Ashburn 158
Shanghai 108
Milan 88
Singapore 76
Moscow 46
New York 38
Boardman 36
Seattle 36
Washington 30
Canberra 20
Lawrence 15
Princeton 15
Bang Kruai 10
Sydney 10
Helsinki 9
Los Angeles 9
Rome 7
Santa Clara 7
Pisa 6
Bari 5
Bologna 5
Lappeenranta 5
Frankfurt am Main 4
London 4
Motta Sant'Anastasia 4
Paderno Dugnano 4
Sham Shui Po 4
Giza 3
Melbourne 3
Mexico City 3
Palermo 3
Parma 3
Pontedera 3
Ankara 2
Athens 2
Bagnoli del Trigno 2
Bengaluru 2
Budrio 2
Casorate Primo 2
Castelfidardo 2
Castenaso 2
Catania 2
Clifton 2
Cuorgnè 2
Ellicott City 2
Forlì 2
Hong Kong 2
Ipiales 2
Loreggia 2
Macerata 2
Manchester 2
Meda 2
Migliarino 2
Nairobi 2
Nanjing 2
Naples 2
Otemae 2
Padova 2
Pavia 2
Rabat 2
Razgrad 2
Riyadh 2
Salò 2
San Vito di Fagagna 2
Sankt Pölten 2
Sedico 2
Seravezza 2
Songpa-gu 2
Tbilisi 2
Temecula 2
Tolentino 2
Turi 2
Vienna 2
Vijayawada 2
Zola Predosa 2
Abbiategrasso 1
Antalya 1
Bergamo 1
Borås 1
Charlotte 1
Civitavecchia 1
Dalmine 1
Dublin 1
Ebisu 1
Essen 1
Fabriano 1
Falkenstein 1
Ferrara 1
Florence 1
Groningen 1
Gunzenhausen 1
Hangzhou 1
Havana 1
Las Vegas 1
Lucca 1
Nerviano 1
Ottawa 1
Pécs 1
Romford 1
San Antonio 1
Totale 886
Nome #
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 40
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 33
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 27
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 24
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study 21
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 20
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 20
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 20
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 19
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial 19
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 18
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 18
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 18
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 18
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 18
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 18
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 18
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 17
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 17
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 17
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 16
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 16
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 16
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 16
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 16
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 15
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 15
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy 15
C-11-Methionine uptake in secondary brain epilepsy 15
Myocardial involvement in systemic sclerosis 15
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 14
Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT 14
Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 14
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units 14
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 14
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 13
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 13
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 13
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 13
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 13
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites 13
Stroke chameleon (cortical hand syndrome) in a patient with moderate carotid stenosis: a neurological double-trouble 13
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging 13
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 13
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 12
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 12
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 12
Advancing EJNMMI: continuing success and next developments 12
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 12
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study 12
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 12
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees 12
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study 12
Assessment of tumor response in malignant pleural mesothelioma 12
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 11
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 11
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 11
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 11
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 11
Radiomics of Liver Metastases: A Systematic Review 11
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 11
Emergency endovascular treatments for delayed hemorrhage after pancreaticobiliary surgery: indications, outcomes, and follow-up of a retrospective cohort 11
STRUCTURAL CHARACTERIZATION OF LOW GRADE GLIOMAS BY INTEGRATION OF MR, ULTRASOUND AND PET IMAGING 11
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study 10
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 10
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 10
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 10
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 10
Reporter gene imaging "visualized" the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy 10
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 10
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy 10
Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging 10
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 10
Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice 10
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 10
Writing PET into existence 10
Consensus on molecular imaging and theranostics in prostate cancer 10
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 10
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study 9
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 9
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 9
European guidelines update on PSMA PET/CT for prostate cancer staging-snap back to reality 9
MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423) 9
Methodological framework for radiomics applications in Hodgkin’s lymphoma 9
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 9
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 9
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper 9
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 9
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 9
Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging 9
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 9
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience 9
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 9
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 9
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 9
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 9
Perceived risk and decision-making: navigating uncertainty in clinical practice 8
Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma 8
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group 8
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 8
Totale 1.325
Categoria #
all - tutte 18.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 2 0 0 0 0 0 0 0 0 2 0 0
2020/20217 0 0 0 3 2 2 0 0 0 0 0 0
2021/20225 0 0 0 5 0 0 0 0 0 0 0 0
2022/2023466 34 16 7 0 0 5 2 6 8 52 324 12
2023/20241.042 16 78 110 70 81 164 63 119 61 76 54 150
2024/2025278 278 0 0 0 0 0 0 0 0 0 0 0
Totale 1.805